Immunic Presents Key Vidofludimus Calcium Data at the ACTRIMS Forum 2025
Vidofludimus Calcium’s Activation of Nurr1 reduces neuronal loss and injury directly and Indirectly by decreasing microglial activations in preclinical models.
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Vidofludimus Calcium’s Activation of Nurr1 reduces neuronal loss and injury directly and Indirectly by decreasing microglial activations in preclinical models.
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.